secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K/A
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0001104659-23-057486
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 1.02, 2.03, 3.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth amends 8-K; clarifies warrant & Series A-1 shares; closed $15.4M equity & $30M loan
--------------------------------------------------------------------------------

- Raised $15.4M gross from sale of Series B, B-1, B-2, B-3 Preferred Stock at $1,000 per share.
- Secured $30M initial tranche from Avenue Venture's $40M credit facility; interest at higher of (prime+4.5%) or 12.5%.
- Issued lenders warrants for 584,884 shares at $3.334/share, 5-year term; terms clarified in this amendment.
- Terminated prior OrbiMed credit agreement upon funding of new loan facility.
- Series A-1 holders can earn up to 382,050 additional common shares for deferring conversion; reduced number clarified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465923057486/0001104659-23-057486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465923057486/tm2315045d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-057486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer